Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.115 AUD | -4.17% | 0.00% | 0.00% |
Mar. 26 | Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise | MT |
Mar. 20 | Arovella Therapeutics' ALA-101-onCARlytics Collaboration with Imugene Ends; Shares Down 12% | MT |
Sales 2022 | 296K 193K | Sales 2023 | 1.45M 950K | Capitalization | 42.5M 27.74M |
---|---|---|---|---|---|
Net income 2022 | -8M -5.22M | Net income 2023 | -10M -6.53M | EV / Sales 2022 | 32 x |
Net cash position 2022 | 5.93M 3.87M | Net cash position 2023 | 5.18M 3.38M | EV / Sales 2023 | 25.7 x |
P/E ratio 2022 |
-1.47
x | P/E ratio 2023 |
-3.49
x | Employees | 27 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.45% |
1 day | -4.17% | ||
Current month | -23.33% | ||
1 month | -11.54% | ||
3 months | -14.81% | ||
6 months | +43.75% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Baker
CEO | Chief Executive Officer | - | 20-01-01 |
Tim Luscombe
DFI | Director of Finance/CFO | - | Nov. 30 |
Michelle Long
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
BRD | Director/Board Member | 62 | 22-06-30 |
Elizabeth Stoner
BRD | Director/Board Member | 73 | 21-11-09 |
Thomas Duthy
CHM | Chairman | - | 23-03-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.115 | -4.17% | 1,618,958 |
24-04-23 | 0.12 | +4.35% | 797,989 |
24-04-22 | 0.115 | +9.52% | 1,518,184 |
24-04-19 | 0.105 | -8.70% | 1,185,259 |
24-04-18 | 0.115 | 0.00% | 2,659,715 |
Delayed Quote Australian S.E., April 24, 2024 at 02:10 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 78.36M | |
+4.09% | 43.84B | |
+46.34% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- ALA Stock